Test Bank:
n2
Advanced Pharmacology for Prescribers 1st Edition Luu Kayingo Latest
n2 n2 n2 n2 n2 n2 n2 n2 n
2 Edition, 2024
n2
, Table of Contents n2 n2
Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines ......................................... 3
n2 n2 n2 n2 n2 n2 n2 n2
Chapter 2: Pharmacokinetics /Chapter3: Pharmacodynamics .................................................................. 13
n2 n2 n2 n2
Chapter4: Pharmacogenetics and Pharmacogenomics............................................................................... 25
n2 n2 n2
Chapter 5: Pharmacology Across the Life Span ...................................................................................... 30
n2 n2 n2 n2 n2 n2
Chapter 6: Drug-Therapy Prescribing in Special Populations ................................................................. 36
n2 n2 n2 n2 n2 n2
Chapter 7: Drug Development and Approval........................................................................................... 45
n2 n2 n2 n2 n2
Chapter 8-Chapter 10: Foundations of Prescription Writing Chapter 9: ResponsibleControlled-
n2 n2 n2 n2 n2 n2 n2 n2 n2
Substance Prescribing Chapter 10: Antibiotic Stewardship ...................................................................... 51
n2 n2 n2 n2 n2
Chapter 11: Applied Calculations for Prescribing ................................................................................... 58
n2 n2 n2 n2 n2
Chapter 12-: Promoting Adherence With Pharmacotherapy II: System-Specific and Patient-
n2 n2 n2 n2 n2 n2 n2 n2 n2
Focused Prescribing Chapter 13: Pharmacotherapy for Ear, Nose, Mouth, andThroat Conditions /Chapt
n2 n2 n2 n2 n2 n2 n2 n2 n2 n2 n2
er 14: Pharmacotherapy for Eye Conditions.............................................................................................. 67
n2 n2 n2 n2 n2
Chapter 15: Pharmacotherapy for Skin Conditions.................................................................................. 74
n2 n2 n2 n2 n2
Chapter 16: Pharmacotherapy for Neurologic Conditions ....................................................................... 81
n2 n2 n2 n2 n2
Chapter 17: Pharmacotherapy for Cardiovascular Conditions ................................................................ 94
n2 n2 n2 n2 n2
Chapter 18: Pharmacotherapy for Respiratory Conditions .................................................................... 106
n2 n2 n2 n2 n2
Chapter 19: Pharmacotherapy for Gastrointestinal Conditions and Conditions RequiringNutritional Sup
n2 n2 n2 n2 n2 n2 n2 n2 n2
port............................................................................................................................................................. 117
Chapter 20: Pharmacotherapy for Genitourinary Conditions ................................................................ 128
n2 n2 n2 n2 n2
Chapter 21: Pharmacotherapy for Renal, Acid–Base, Fluid, and Electrolyte Disorders ..................... 133
n2 n2 n2 n2 n2 n2 n2 n2 n2
Chapter 22: Pharmacotherapy for Musculoskeletal and Rheumatologic Conditions........................... 146
n2 n2 n2 n2 n2 n2 n2
Chapter 23: Therapeutic Applications of Immunology and Vaccines ................................................. 158
n2 n2 n2 n2 n2 n2 n2
Chapter 24: Pharmacotherapy for Endocrine Disorders ........................................................................ 163
n2 n2 n2 n2 n2
Chapter 25: Pharmacotherapy for Hematologic Disorders .................................................................... 174
n2 n2 n2 n2 n2
Chapter 26: Hematology/Oncology and Supportive Care for the Nononcologist ................................ 190
n2 n2 n2 n2 n2 n2 n2 n2
Chapter 27: Pharmacotherapy Related to Women’s Health Conditions .............................................. 196
n2 n2 n2 n2 n2 n2 n2
Chapter 28: Pharmacotherapy Related to Men’s Health Conditions .................................................... 211
n2 n2 n2 n2 n2 n2 n2
Chapter 29: Pharmacotherapy Related to Transgender Care ................................................................ 217
n2 n2 n2 n2 n2 n2
Chapter 30: Antimicrobial Pharmacotherapy .......................................................................................... 224
n2 n2 n2
Chapter 31: Antiretroviral Pharmacotherapy........................................................................................... 235
n2 n2 n2
Chapter 32: Psychopharmacology and Integrative Health: Combined Treatment ofPsychiatric and Neur
n2 n2 n2 n2 n2 n2 n2 n2 n2 n2
ocognitive Conditions ................................................................................................................................ 247
n2
Chapter 33: Pharmacotherapy for Pain Management ............................................................................ 257
n2 n2 n2 n2 n2
Chapter 34: Substance Use Disorder III: Health Promotion and Maintenance.................................... 267
n2 n2 n2 n2 n2 n2 n2 n2 n2
Chapter 35: Over-the-Counter Medications ............................................................................................ 283
n2 n2 n2
Chapter 36: Pharmacotherapy for Obesity .............................................................................................. 291
n2 n2 n2 n2
,Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines
n2 n2 n2 n2 n2 n2 n2 n2
MULTIPLE CHOICE n2
• What is the primary purpose of the nursing assessment?
n2 n2 n2 n2 n2 n2 n2 n2
A. Identifying underlying pathologic conditions n2 n2 n2
B. Assisting the physician in identifying medical conditions
n2 n2 n2 n2 n2 n2
C. Determining the patients mental status n2 n2 n2 n2
D. Exploring patient responses to health problems n2 n2 n2 n2 n2
ANS: D n2
A nursing assessment is done to identify the patients response to health
n2 n2 n2 n2 n2 n2 n2 n2 n2 n2 n2 n2
problems. During the nursing assessment phase, a comprehensive inform
n2 n2 n2 n2 n2 n2 n2 n2
ation base is developed through a physical examination, nursing history,
n2 n2 n2 n2 n2 n2 n2 n2 n2 n
medication history, and professional observation. Identifying underlying
2 n2 n2 n2 n2 n2 n2 n
pathologic conditions and assisting the physician in identifying medical
2 n2 n2 n2 n2 n2 n2 n2 n2 n2
conditions is not part of the nursing process. Determining the patients
n2 n2 n2 n2 n2 n2 n2 n2 n2 n2 n2
mental status is one part of the nursing assessment, but it is not the
n2 n2 n2 n2 n2 n2 n2 n2 n2 n2 n2 n2 n2 n
primary purpose.
2 n2
DIF: Cognitive Level: Comprehension
n2 n2 n2
REF: dm 36 OBJ: 1 | 3 TOP: Nursin
n2 n2 n2 n2 n2 n2 n2 n2 n2
g Process Step: Assessment
n2 n2 n2
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
n2 n2 n2 n2 n2 n2 n2 n2
• What is the basis of the NANDA I taxonomy?
n2 n2 n2 n2 n2 n2 n2 n 2
A. Functional health patterns n2 n2
B. Human response patterns n2 n2
C. Basic human needs n2 n2
D. Pathophysiologic needs n2
ANS: B n2
The NANDA I taxonomy identifies human response patterns. Fu
n 2 n 2 n 2 n 2 n 2 n 2 n 2 n2
nctional components of health patterns are limited to activity, fluid vol
n2 n2 n2 n2 n2 n2 n2 n2 n2 n2
ume, nutrition, self care, and sensory perception. Basic human needs c
n2 n2 n2 n2 n2 n2 n2 n2 n2 n2
omprise less than merely health patterns. Pathophysiologic needs are
n2 n2 n2 n2 n2 n2 n2 n2 n 2
not part of the scope of NANDA I.
n2 n2 n2 n2 n2 n2 n2
, DIF: Cognitive Level: Knowledge RE
n2 n2 n2 n2
F: pp. 37-38 OBJ: 5 TOP:
n2 n2 n2 n2 n2
Nursing Process Step: Diagnosis
n2 n2 n2
MSC: NCLEX Client Needs Category: Physiological Integrity
n2 n2 n2 n2 n2 n2
• Which task is included in the assessment step of the nursing process?
n2 n2 n2 n2 n2 n2 n2 n2 n2 n2 n2
A. Establishing patient goals/outcomes n2 n2
B. Implementing the nursing care plan (NCP) n2 n2 n2 n2 n2
C. Measuring goal/outcome achievement n2 n2
D. Collecting and communicating data n2 n2 n2
ANS: D n2
Data are collected and communicated in the assessment phase of the nur
n2 n2 n2 n2 n2 n2 n2 n2 n2 n2 n2
sing process. Establishing goals is the function of planning.
n2 n2 n2 n2 n2 n2 n2 n2
Implementing the NCP is the function of implementation. Measuring out
n2 n2 n2 n2 n2 n2 n2 n2 n2
come achievement is the function of evaluation.
n2 n2 n2 n2 n2 n2
DIF: Cognitive Level: Comprehensio
n2 n2 n2
n REF: dm 36 OBJ: 2 | 3 TOP: Nursi
n2 n2 n2 n2 n2 n2 n2 n2 n2
ng Process Step: Assessment
n2 n2 n2
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
n2 n2 n2 n2 n2 n2 n2 n2
• Which statement regarding nursing diagnoses is accurate?
n2 n2 n2 n2 n2 n2
a. Nursing diagnoses remain the same for as long as the disease is present.
n2 n2 n2 n2 n2 n2 n2 n2 n2 n2 n2 n2
b. Nursing diagnoses are written to identify disease states.
n2 n2 n2 n2 n2 n2 n2
c. Nursing diagnoses describe patient problems that nurses treat.
n2 n2 n2 n2 n2 n2 n2
d. Nursing diagnoses identify causes related to illness.
n2 n2 n2 n2 n2 n2
ANS: C n2
Diagnostic statements identify problems a nurse is independently able t
n2 n2 n2 n2 n2 n2 n2 n2 n2
o treat within the scope of professional practice. Nursing diagnoses var
n2 n2 n2 n2 n2 n2 n2 n2 n2 n2
y with the changing condition of the patient. The response patterns are
n2 n2 n2 n2 n2 n2 n2 n2 n2 n2 n2 n2
unique to the patient and are not disease specific. Nursing diagnoses de
n2 n2 n2 n2 n2 n2 n2 n2 n2 n2 n2
scribe the patients human response pattern.
n2 n2 n2 n2 n2
DIF: Cognitive Level: Comprehension
n2 n2 n2
n2
Advanced Pharmacology for Prescribers 1st Edition Luu Kayingo Latest
n2 n2 n2 n2 n2 n2 n2 n2 n
2 Edition, 2024
n2
, Table of Contents n2 n2
Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines ......................................... 3
n2 n2 n2 n2 n2 n2 n2 n2
Chapter 2: Pharmacokinetics /Chapter3: Pharmacodynamics .................................................................. 13
n2 n2 n2 n2
Chapter4: Pharmacogenetics and Pharmacogenomics............................................................................... 25
n2 n2 n2
Chapter 5: Pharmacology Across the Life Span ...................................................................................... 30
n2 n2 n2 n2 n2 n2
Chapter 6: Drug-Therapy Prescribing in Special Populations ................................................................. 36
n2 n2 n2 n2 n2 n2
Chapter 7: Drug Development and Approval........................................................................................... 45
n2 n2 n2 n2 n2
Chapter 8-Chapter 10: Foundations of Prescription Writing Chapter 9: ResponsibleControlled-
n2 n2 n2 n2 n2 n2 n2 n2 n2
Substance Prescribing Chapter 10: Antibiotic Stewardship ...................................................................... 51
n2 n2 n2 n2 n2
Chapter 11: Applied Calculations for Prescribing ................................................................................... 58
n2 n2 n2 n2 n2
Chapter 12-: Promoting Adherence With Pharmacotherapy II: System-Specific and Patient-
n2 n2 n2 n2 n2 n2 n2 n2 n2
Focused Prescribing Chapter 13: Pharmacotherapy for Ear, Nose, Mouth, andThroat Conditions /Chapt
n2 n2 n2 n2 n2 n2 n2 n2 n2 n2 n2
er 14: Pharmacotherapy for Eye Conditions.............................................................................................. 67
n2 n2 n2 n2 n2
Chapter 15: Pharmacotherapy for Skin Conditions.................................................................................. 74
n2 n2 n2 n2 n2
Chapter 16: Pharmacotherapy for Neurologic Conditions ....................................................................... 81
n2 n2 n2 n2 n2
Chapter 17: Pharmacotherapy for Cardiovascular Conditions ................................................................ 94
n2 n2 n2 n2 n2
Chapter 18: Pharmacotherapy for Respiratory Conditions .................................................................... 106
n2 n2 n2 n2 n2
Chapter 19: Pharmacotherapy for Gastrointestinal Conditions and Conditions RequiringNutritional Sup
n2 n2 n2 n2 n2 n2 n2 n2 n2
port............................................................................................................................................................. 117
Chapter 20: Pharmacotherapy for Genitourinary Conditions ................................................................ 128
n2 n2 n2 n2 n2
Chapter 21: Pharmacotherapy for Renal, Acid–Base, Fluid, and Electrolyte Disorders ..................... 133
n2 n2 n2 n2 n2 n2 n2 n2 n2
Chapter 22: Pharmacotherapy for Musculoskeletal and Rheumatologic Conditions........................... 146
n2 n2 n2 n2 n2 n2 n2
Chapter 23: Therapeutic Applications of Immunology and Vaccines ................................................. 158
n2 n2 n2 n2 n2 n2 n2
Chapter 24: Pharmacotherapy for Endocrine Disorders ........................................................................ 163
n2 n2 n2 n2 n2
Chapter 25: Pharmacotherapy for Hematologic Disorders .................................................................... 174
n2 n2 n2 n2 n2
Chapter 26: Hematology/Oncology and Supportive Care for the Nononcologist ................................ 190
n2 n2 n2 n2 n2 n2 n2 n2
Chapter 27: Pharmacotherapy Related to Women’s Health Conditions .............................................. 196
n2 n2 n2 n2 n2 n2 n2
Chapter 28: Pharmacotherapy Related to Men’s Health Conditions .................................................... 211
n2 n2 n2 n2 n2 n2 n2
Chapter 29: Pharmacotherapy Related to Transgender Care ................................................................ 217
n2 n2 n2 n2 n2 n2
Chapter 30: Antimicrobial Pharmacotherapy .......................................................................................... 224
n2 n2 n2
Chapter 31: Antiretroviral Pharmacotherapy........................................................................................... 235
n2 n2 n2
Chapter 32: Psychopharmacology and Integrative Health: Combined Treatment ofPsychiatric and Neur
n2 n2 n2 n2 n2 n2 n2 n2 n2 n2
ocognitive Conditions ................................................................................................................................ 247
n2
Chapter 33: Pharmacotherapy for Pain Management ............................................................................ 257
n2 n2 n2 n2 n2
Chapter 34: Substance Use Disorder III: Health Promotion and Maintenance.................................... 267
n2 n2 n2 n2 n2 n2 n2 n2 n2
Chapter 35: Over-the-Counter Medications ............................................................................................ 283
n2 n2 n2
Chapter 36: Pharmacotherapy for Obesity .............................................................................................. 291
n2 n2 n2 n2
,Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines
n2 n2 n2 n2 n2 n2 n2 n2
MULTIPLE CHOICE n2
• What is the primary purpose of the nursing assessment?
n2 n2 n2 n2 n2 n2 n2 n2
A. Identifying underlying pathologic conditions n2 n2 n2
B. Assisting the physician in identifying medical conditions
n2 n2 n2 n2 n2 n2
C. Determining the patients mental status n2 n2 n2 n2
D. Exploring patient responses to health problems n2 n2 n2 n2 n2
ANS: D n2
A nursing assessment is done to identify the patients response to health
n2 n2 n2 n2 n2 n2 n2 n2 n2 n2 n2 n2
problems. During the nursing assessment phase, a comprehensive inform
n2 n2 n2 n2 n2 n2 n2 n2
ation base is developed through a physical examination, nursing history,
n2 n2 n2 n2 n2 n2 n2 n2 n2 n
medication history, and professional observation. Identifying underlying
2 n2 n2 n2 n2 n2 n2 n
pathologic conditions and assisting the physician in identifying medical
2 n2 n2 n2 n2 n2 n2 n2 n2 n2
conditions is not part of the nursing process. Determining the patients
n2 n2 n2 n2 n2 n2 n2 n2 n2 n2 n2
mental status is one part of the nursing assessment, but it is not the
n2 n2 n2 n2 n2 n2 n2 n2 n2 n2 n2 n2 n2 n
primary purpose.
2 n2
DIF: Cognitive Level: Comprehension
n2 n2 n2
REF: dm 36 OBJ: 1 | 3 TOP: Nursin
n2 n2 n2 n2 n2 n2 n2 n2 n2
g Process Step: Assessment
n2 n2 n2
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
n2 n2 n2 n2 n2 n2 n2 n2
• What is the basis of the NANDA I taxonomy?
n2 n2 n2 n2 n2 n2 n2 n 2
A. Functional health patterns n2 n2
B. Human response patterns n2 n2
C. Basic human needs n2 n2
D. Pathophysiologic needs n2
ANS: B n2
The NANDA I taxonomy identifies human response patterns. Fu
n 2 n 2 n 2 n 2 n 2 n 2 n 2 n2
nctional components of health patterns are limited to activity, fluid vol
n2 n2 n2 n2 n2 n2 n2 n2 n2 n2
ume, nutrition, self care, and sensory perception. Basic human needs c
n2 n2 n2 n2 n2 n2 n2 n2 n2 n2
omprise less than merely health patterns. Pathophysiologic needs are
n2 n2 n2 n2 n2 n2 n2 n2 n 2
not part of the scope of NANDA I.
n2 n2 n2 n2 n2 n2 n2
, DIF: Cognitive Level: Knowledge RE
n2 n2 n2 n2
F: pp. 37-38 OBJ: 5 TOP:
n2 n2 n2 n2 n2
Nursing Process Step: Diagnosis
n2 n2 n2
MSC: NCLEX Client Needs Category: Physiological Integrity
n2 n2 n2 n2 n2 n2
• Which task is included in the assessment step of the nursing process?
n2 n2 n2 n2 n2 n2 n2 n2 n2 n2 n2
A. Establishing patient goals/outcomes n2 n2
B. Implementing the nursing care plan (NCP) n2 n2 n2 n2 n2
C. Measuring goal/outcome achievement n2 n2
D. Collecting and communicating data n2 n2 n2
ANS: D n2
Data are collected and communicated in the assessment phase of the nur
n2 n2 n2 n2 n2 n2 n2 n2 n2 n2 n2
sing process. Establishing goals is the function of planning.
n2 n2 n2 n2 n2 n2 n2 n2
Implementing the NCP is the function of implementation. Measuring out
n2 n2 n2 n2 n2 n2 n2 n2 n2
come achievement is the function of evaluation.
n2 n2 n2 n2 n2 n2
DIF: Cognitive Level: Comprehensio
n2 n2 n2
n REF: dm 36 OBJ: 2 | 3 TOP: Nursi
n2 n2 n2 n2 n2 n2 n2 n2 n2
ng Process Step: Assessment
n2 n2 n2
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
n2 n2 n2 n2 n2 n2 n2 n2
• Which statement regarding nursing diagnoses is accurate?
n2 n2 n2 n2 n2 n2
a. Nursing diagnoses remain the same for as long as the disease is present.
n2 n2 n2 n2 n2 n2 n2 n2 n2 n2 n2 n2
b. Nursing diagnoses are written to identify disease states.
n2 n2 n2 n2 n2 n2 n2
c. Nursing diagnoses describe patient problems that nurses treat.
n2 n2 n2 n2 n2 n2 n2
d. Nursing diagnoses identify causes related to illness.
n2 n2 n2 n2 n2 n2
ANS: C n2
Diagnostic statements identify problems a nurse is independently able t
n2 n2 n2 n2 n2 n2 n2 n2 n2
o treat within the scope of professional practice. Nursing diagnoses var
n2 n2 n2 n2 n2 n2 n2 n2 n2 n2
y with the changing condition of the patient. The response patterns are
n2 n2 n2 n2 n2 n2 n2 n2 n2 n2 n2 n2
unique to the patient and are not disease specific. Nursing diagnoses de
n2 n2 n2 n2 n2 n2 n2 n2 n2 n2 n2
scribe the patients human response pattern.
n2 n2 n2 n2 n2
DIF: Cognitive Level: Comprehension
n2 n2 n2
